When was Third Pole Therapeutics founded?

Third Pole Therapeutics was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Where is Third Pole Therapeutics located?

Third Pole Therapeutics is headquartered in Boston, United States.

How many employees does Third Pole Therapeutics have?

As of Sep 30, 2026, the latest employee count at Third Pole Therapeutics is 29.

Is Third Pole Therapeutics a funded company?

Third Pole Therapeutics is a funded company, having raised a total of $87.6M across 5 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Jan 16, 2018.

When was the latest funding round of Third Pole Therapeutics?

Third Pole Therapeutics' latest funding was a $***** Series B round on Mar 18, 2024, with participation from 0 investor.

Where does Third Pole Therapeutics rank among its competitors?

Third Pole Therapeutics ranks 16th amongst 208 active competitors, of which 40 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Cloud, which secured $578K in Mar, 2026.

Who are the top competitors of Third Pole Therapeutics?

Third Pole Therapeutics' top competitors include Withings, Biotricity and Microlife. Among them, Cloud secured the most recent funding round in March, 2026.

Third Pole Therapeutics - 2026 Company Profile, Funding & Competitors

Third Pole Therapeutics is a series B company based in Boston (United States), founded in 2014. It operates as a Developer of devices for cardiopulmonary therapies. Third Pole Therapeutics has raised $87.6M in funding. The company has 208 active competitors, including 40 funded and 25 that have exited. Its top competitors include companies like Withings, Biotricity and Microlife.

Company Details

Developer of devices for cardiopulmonary therapies. The company is developing a device offering nitric oxide (NO) from iridium electrodes for infant acute pulmonary hypertension, heart, and lung therapies. The inhaled nitric oxide therapy delivery system relaxes the blood vessels lowering the blood pressure.

Website: www.pole3.com/
Email ID: *****@pole3.com
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Boston, United States

Stage

Series B

Total Funding

$87.6M in 5 rounds

Latest Funding Round

Series B, Mar 18, 2024, $*****

Investors

Saturn Partners & 5 more

Ranked

16^th among 208 active competitors

Employee Count

29 as on Sep 30, 2026

Similar Companies

Withings & 326 more

View Third Pole Therapeutics' full profile

Third Pole Therapeutics has raised a total funding of $87.6M over 5 rounds. Its first funding round was on Jan 16, 2018. Third Pole Therapeutics has 6 institutional investors.

Here is the list of recent funding rounds of Third Pole Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 18, 2024	5573202	Series B	6147536	7252395	7995980	5248866
Dec 14, 2022	2275203	Series B	8772297	1581237	1165012	6516541
Feb 03, 2022	2462138	Series B	2748435	7511056	6195516	8230600

Access funding benchmarks and valuations. Sign up today!

View details of Third Pole Therapeutics's funding rounds and investors

Third Pole Therapeutics' employee count trend

Third Pole Therapeutics has 29 employees as of Sep 26. Here is Third Pole Therapeutics's employee count trend over the years:

Employee count trend for Third Pole Therapeutics

Uncover Third Pole Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Third Pole Therapeutics include Withings, Biotricity and Microlife. Here is the list of Top 10 competitors of Third Pole Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Withings 2008, Moulineaux (France), Acquired	Developer of an array of connected products	$93.8M	Bpifrance, Gilde Healthcare & 8 others	82/100
2nd	Biotricity 2014, San Francisco (United States), Public	Developer of medical remote monitoring solutions that help prevent and manage chronic diseases	-	SWK Holdings, National Research Council Canada ... & 2 others	62/100
3rd	Microlife 1981, Taipei (Taiwan), Public	Portfolio of thermometers and blood pressure monitors	-	Morgan Stanley Private Equity Asia	56/100
4th	Qardio 2012, San Francisco (United States), Series B	Manufacturer of digital health devices for remote patient monitoring systems	$29.1M	Scranton, AyBe & 4 others	53/100
5th	apreo health 2021, Menlo Park (United States), Series B	Developer of investigational solutions focused on treating and managing lung disease	$130M	Bain Capital Life Sciences, Norwest & 4 others	51/100
6th	MC10 2008, Cambridge (United States), Series C	Miniaturized embedded sensors	$118M	Medtronic, Aberdare Ventures & 7 others	50/100
7th	Cloud 2014, Brooklyn (United States), Series A	Provider of cloud-based remote cardiology vital signs monitoring devices and platforms	$3.13M	FedDev Ontario, Accelerator Centre & 1 others	49/100
8th	Vyaire 2016, Illinois City (United States), Acquired	Medical devices and software solutions for emergency, critical, and cardiac care	$31.5M	BD	46/100
9th	Sentec 1999, Therwil (Switzerland), Unfunded	Developer of noninvasive monitoring and intrapulmonary percussive ventilation solutions	-	-	45/100
10th	A&D Engineering 1977, San Jose (United States), Unfunded	Precision measurement and product inspection equipment for healthcare, laboratory, and industrial markets	-	-	45/100
16th	Third Pole Therapeutics 2014, Boston (United States), Series B	Developer of devices for cardiopulmonary therapies	$87.6M	Saturn Partners, JLABS & 4 others	41/100